A detailed history of Brady Family Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Brady Family Wealth, LLC holds 6,019 shares of ABBV stock, worth $1.01 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
6,019
Previous 6,019 -0.0%
Holding current value
$1.01 Million
Previous $933 Million 17.51%
% of portfolio
0.36%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $112,969 - $127,230
-821 Reduced 12.0%
6,019 $933 Million
Q3 2023

Oct 27, 2023

SELL
$133.59 - $154.65 $18,702 - $21,651
-140 Reduced 2.01%
6,840 $1.02 Billion
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $19,522 - $22,482
-135 Reduced 1.9%
6,980 $1.11 Billion
Q4 2022

Apr 10, 2023

BUY
$138.31 - $165.87 $984,075 - $1.18 Million
7,115 New
7,115 $1.15 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brady Family Wealth, LLC Portfolio

Follow Brady Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brady Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brady Family Wealth, LLC with notifications on news.